AC Immune
ACIU
AC Immune (ACIU) news
Recent news
AC Immune - full Phase 1/1B results for ACI-19764 expected in H1 2027
AInvest Wire · Aug 20, 2026AC Immune announces positive preliminary Phase 1 data for NLRP3 inhibitor ACI-19764
AInvest Wire · Aug 20, 2026AC Immune gets FDA fast track designation for ACI-7104
AInvest Wire · Aug 11, 2026AC Immune - interim results show safety and immunogenicity with early signals of activity for ACI-7104
AInvest Wire · Aug 11, 2026AC Immune - full week-100 results from Part 1 Vacsyn trial expected in H2 2026
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.